MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-30-2026
Merit Medical Systems Cash Conversion Cycle 2011-2026 | MMSI
Annual Cash Conversion Cycle Merit Medical Systems
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 167 | 171 | 168 | 155 | 148 | 161 | 173 | 169 | 168 | 149 | 134 | 137 | 132 | 139 | 135 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 173 | 132 | 154 |
Quarterly Cash Conversion Cycle Merit Medical Systems
| 2026-Q1 | 2025-Q4 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 178 | - | 165 | 172 | - | 173 | 177 | 181 | - | 181 | 176 | 172 | - | 77.5 | 73.6 | 151 | - | 145 | 134 | 153 | 51.9 | 150 | 162 | 161 | 55 | 171 | 164 | 163 | 53.7 | 166 | 161 | 159 | 50.5 | 165 | 159 | 49.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 40.6 | 40.9 | 40.5 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 181 | 40.5 | 132 |
Cash Conversion Cycle of other stocks in the Medical instruments industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
ICU Medical
ICUI
|
146 | $ 129.31 | 4.57 % | $ 3.19 B |  USA |
 |
Atrion Corporation
ATRI
|
253 K | - | - | $ 810 M | USA |
 |
Intuitive Surgical
ISRG
|
203 | $ 449.03 | 1.69 % | $ 160 B | USA |
 |
The Cooper Companies
COO
|
210 | $ 61.75 | 0.49 % | $ 12.3 B | USA |
 |
Luminex Corporation
LMNX
|
18.9 | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
95.3 | - | -9.52 % | $ 20.6 M | USA |
 |
Repro Med Systems
KRMD
|
83.1 | $ 4.0 | 1.01 % | $ 185 M | USA |
 |
Alcon
ALC
|
134 | $ 67.28 | 1.51 % | $ 40.4 B |  Schweiz |
 |
LeMaitre Vascular
LMAT
|
29 | $ 101.43 | 0.1 % | $ 2.3 B | USA |
 |
Masimo Corporation
MASI
|
83.7 | $ 178.79 | -0.01 % | $ 9.53 B | USA |
 |
iRhythm Technologies
IRTC
|
59.8 | $ 117.0 | 2.78 % | $ 3.74 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
204 | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
400 | - | -1.18 % | $ 3.4 B | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
11.9 | - | -0.05 % | $ 10.3 B | USA |
 |
Milestone Scientific
MLSS
|
543 | $ 0.4 | 14.99 % | $ 32.8 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
404 | - | - | $ 28.6 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
194 | - | -0.02 % | $ 16.3 B | USA |
 |
electroCore
ECOR
|
-39.3 | $ 6.13 | 3.81 % | $ 52 K | USA |
 |
Envista Holdings Corporation
NVST
|
77.3 | $ 23.77 | 3.12 % | $ 3.99 B | USA |
 |
Haemonetics Corporation
HAE
|
217 | $ 59.56 | 4.77 % | $ 3 B | USA |
 |
STERIS plc
STE
|
112 | $ 215.97 | 0.72 % | $ 21.3 B | USA |
 |
Isoray
ISR
|
353 | - | 0.03 % | $ 108 M | USA |
 |
Glaukos Corporation
GKOS
|
170 | $ 143.82 | 2.8 % | $ 6.97 B | USA |
 |
Utah Medical Products
UTMD
|
321 | $ 64.17 | 0.27 % | $ 208 M | USA |
 |
STAAR Surgical Company
STAA
|
1.12 | $ 33.05 | 1.38 % | $ 1.64 B | USA |
 |
InfuSystem Holdings
INFU
|
30.8 | $ 10.16 | 5.07 % | $ 210 M | USA |
 |
Microbot Medical
MBOT
|
-34.9 | $ 1.74 | 0.58 % | $ 79.7 M |  Israel |
 |
Teleflex Incorporated
TFX
|
285 | $ 135.18 | 1.84 % | $ 6.03 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
66 | $ 9.84 | 1.03 % | $ 1.96 B | USA |
 |
West Pharmaceutical Services
WST
|
97.3 | $ 305.5 | 0.52 % | $ 22.1 B | USA |
 |
Pulse Biosciences
PLSE
|
-1.32 K | $ 26.09 | 4.57 % | $ 1.76 B | USA |
 |
Retractable Technologies
RVP
|
203 | $ 0.66 | -2.35 % | $ 19.8 M | USA |
 |
Pro-Dex
PDEX
|
193 | $ 63.47 | 4.43 % | $ 209 M | USA |
 |
Predictive Oncology
POAI
|
-7.04 K | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
322 | $ 24.0 | 4.12 % | $ 1.15 B | USA |
 |
Stereotaxis
STXS
|
143 | $ 1.85 | 6.94 % | $ 168 M | USA |
 |
Baxter International
BAX
|
106 | $ 18.77 | 2.4 % | $ 9.63 B | USA |
 |
ResMed
RMD
|
167 | $ 209.86 | 1.0 % | $ 30.7 B | USA |
 |
AtriCure
ATRC
|
185 | $ 29.0 | 0.69 % | $ 1.38 B | USA |
 |
Harvard Bioscience
HBIO
|
243 | $ 5.4 | 7.78 % | $ 240 M | USA |
 |
NeuroMetrix
NURO
|
357 | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
124 | $ 11.81 | 3.23 % | $ 482 M | USA |
 |
Becton, Dickinson and Company
BDX
|
110 | $ 146.95 | - | $ 42.3 B | USA |
 |
Nephros
NEPH
|
150 | $ 3.57 | -1.79 % | $ 37.9 M | USA |
 |
OraSure Technologies
OSUR
|
211 | $ 3.07 | -0.32 % | $ 226 M | USA |
 |
Repligen Corporation
RGEN
|
203 | $ 111.74 | 2.97 % | $ 6.28 M | USA |